Latest News from Health Policy & Management

A YSPH-led research team is investigating innovative new ways to identify and mitigate outbreaks of HIV among people who use drugs.

Dr. Peter Hotez, MD, PhD, has been selected as the 2024 recipient of the prestigious C.-E. A. Winslow Medal. This award honors individuals whose work embodies the ideals of C.-E. A. Winslow, the founder of our school and a pioneer of modern public health.

There's some good news about potential blockbuster benefits of weight loss drugs; and some serious concerns.

New COVID-19 vaccines are now available at local pharmacies, health clinics, major retail outlets, and medical offices. Shots for respiratory syncytial virus (RSV) are also widely available, as is the latest updated flu vaccine. YSPH Associate Professor Jason Schwartz discusses this year's vaccines and why it is important to get vaccinated.

Yale School of Public Health Dean Megan L. Ranney, MD, MPH, was honored today as one of 50 individuals and companies driving advances in medicine, fostering innovation, and shaping the future of biopharma and health care. Ranney was honored in the ‘Social Impact’ category for her leadership, research, and advocacy in working to prevent firearm injuries.

Joseph Ross, MD, MHS, professor of medicine (general medicine) at Yale School of Medicine, discusses the reliability of Apple's enhanced health screening tools.

The 14-year-old boy accused of killing two students and a pair of teachers at Georgia’s Apalachee High on Wednesday would be the youngest mass school shooter in a quarter-century, according to a Washington Post analysis. YSPH Dean Megan Ranney says potential gun violence interventions should extend beyond the criminal justice system to include parents, educators, and health professionals.

Polio has made a comeback in the Gaza Strip after 25 years, forcing the United Nations and local health authorities to launch a vaccination campaign. YSPH Professor Howard Forman explains how the current outbreak could be driven by vaccine-derived cases.

Harlan Krumholz MD, SM, Harold H. Hines Jr. Professor of Medicine at Yale School of Medicine, director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation, and professor of public health (health policy) at the Yale School of Public Health, comments on studies suggesting people taking weight loss drugs are less likely to die of COVID-19.